Canon Inc.
CAJ · New York Stock Exchange · USD
21,63USD
0,00 (0,00 %)Stand 6. März, 21:00
Kennzahlen
- Eröffnung
- 21,63
- Vortag
- 21,66
- Tagesspanne
- 21,59 – 21,79
- 52 Wochen
- 20,84 – 25,79
- Volumen
- 933.985
- Ø Volumen
- 442.600
- Börsenwert
- 21,97 Mrd. $
- KGV
- 14,6
- Gewinn je Aktie (TTM)
- 254,03
- Dividendenrendite
- 4,1 %
- Beta
- 0,5
- Nächste Zahlen
- –
Finanzen
| JPY | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Umsatz | 4,03 Bio. | 3,51 Bio. | 3,16 Bio. | 3,59 Bio. | 3,95 Bio. |
| Herstellungskosten | 2,2 Bio. | 1,89 Bio. | 1,78 Bio. | 1,98 Bio. | 2,12 Bio. |
| Bruttogewinn | 1,83 Bio. | 1,63 Bio. | 1,38 Bio. | 1,61 Bio. | 1,84 Bio. |
| Forschung und Entwicklung | 306,73 Mrd. | 287,34 Mrd. | 272,31 Mrd. | 298,5 Mrd. | 315,84 Mrd. |
| Vertrieb und Verwaltung | 1,17 Bio. | 1,06 Bio. | 993,01 Mrd. | 1,14 Bio. | 1,18 Bio. |
| Operatives Ergebnis | 353,4 Mrd. | 281,92 Mrd. | 110,55 Mrd. | 174,67 Mrd. | 342,95 Mrd. |
| EBITDA | 579,98 Mrd. | 524,6 Mrd. | 358,96 Mrd. | 434,11 Mrd. | 601,26 Mrd. |
| Nettogewinn | 243,96 Mrd. | 214,72 Mrd. | 83,32 Mrd. | 125,11 Mrd. | 252,76 Mrd. |
| Gewinn je Aktie (verwässert) | 236,63 | 205,29 | 79,35 | 116,91 | 234,08 |
Umsatz nach Segment
Produkte · FY 2022
- Products And Equipment5,06 Bio. ¥81,16 %
- Service1,17 Bio. ¥18,84 %+12,79 %
Anteil · ggü. Vorjahr (FY 2021)
Regionen · FY 2022
- UNITED STATES1,18 Bio. ¥100,00 %+30,30 %
Anteil · ggü. Vorjahr (FY 2021)
Bewertung
Letzte 12 Monate
- KGV
- 14,6
- Kurs-Umsatz-Verhältnis
- 0,9
- Kurs-Buchwert-Verhältnis
- 1,1
- PEG
- 0,7
- Bruttomarge
- 45,3 %
- Operative Marge
- 8,8 %
- Nettomarge
- 6,1 %
- Verschuldungsgrad
- 0,1
- EV/EBITDA
- 6,1
- Eigenkapitalrendite
- 8,1 %
- Kapitalrendite (ROIC)
- 6,3 %
- Free-Cashflow-Rendite
- 2,1 %
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | |
|---|---|---|---|---|---|
| Bruttomarge | 45,3 % | 46,3 % | 43,5 % | 44,8 % | 46,4 % |
| Operative Marge | 8,8 % | 8,0 % | 3,5 % | 4,9 % | 8,7 % |
| Nettomarge | 6,1 % | 6,1 % | 2,6 % | 3,5 % | 6,4 % |
| KGV | 12,0 | 13,7 | 25,3 | 25,4 | 12,9 |
| Kurs-Umsatz-Verhältnis | 0,7 | 0,8 | 0,7 | 0,9 | 0,8 |
| Kurs-Buchwert-Verhältnis | 0,9 | 1,0 | 0,8 | 1,2 | 1,2 |
| Verschuldungsgrad | 0,1 | 0,1 | 0,2 | 0,2 | 0,1 |
| Liquidität 3. Grades | 1,6 | 1,8 | 1,3 | 1,9 | 2,0 |
| Dividendenrendite | 4,1 % | 3,0 % | 6,0 % | 5,4 % | 5,5 % |
| Unternehmenswert | 2,98 Bio. | 2,86 Bio. | 2,2 Bio. | 3,28 Bio. | 3,15 Bio. |
| EV/EBITDA | 5,1 | 5,5 | 6,1 | 7,6 | 5,2 |
| Eigenkapitalrendite | 7,8 % | 7,5 % | 3,2 % | 4,6 % | 8,9 % |
| Kapitalrendite (ROIC) | 6,3 % | 5,6 % | 2,1 % | 3,1 % | 6,4 % |
| Free-Cashflow-Rendite | 2,5 % | 9,3 % | 8,0 % | 4,5 % | 5,3 % |
Wachstum
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | |
|---|---|---|---|---|---|
| Umsatz | +14,7 % | +11,2 % | −12,1 % | −9,1 % | −3,1 % |
| Bruttogewinn | +12,3 % | +18,3 % | −14,5 % | −12,3 % | −7,9 % |
| Operatives Ergebnis | +25,4 % | +155,0 % | −36,7 % | −49,1 % | +3,5 % |
| Nettogewinn | +13,6 % | +157,7 % | −33,4 % | −50,5 % | +4,5 % |
| Gewinn je Aktie | +15,3 % | +158,7 % | −32,1 % | −50,1 % | +5,0 % |
| Freier Cashflow | −72,9 % | +61,9 % | +18,4 % | −17,9 % | −56,6 % |
| Dividende je Aktie | +36,2 % | −29,7 % | −24,6 % | −2,9 % | +9,9 % |
Analysten
Einstufungen · Buy
- 0Stark kaufen
- 3Kaufen
- 3Halten
- 1Verkaufen
- 0Stark verkaufen
Kursziel
Gerade nicht verfügbar.
Letzte Änderungen
- JP Morgan7. Okt. 2021Neutral → Overweight
- JP Morgan13. Sept. 2018Neutral → Underweight
- JP Morgan6. März 2017Neutral → Overweight
- JP Morgan26. Okt. 2016Neutral → Underweight
- CLSA15. Juli 2016Buy → Underperform
- Goldman Sachs6. Juli 2015Sell → Neutral
- JP Morgan24. März 2015Underweight → Overweight
- JP Morgan23. März 2015Neutral → Overweight
Quartalszahlen
| Apr. 2023 | März 2023 | Okt. 2022 | Juli 2022 | Apr. 2022 | März 2022 | Okt. 2021 | Juli 2021 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | 0,47 | – | 0,48 | 0,50 | 0,44 | – | 0,44 | 0,42 |
| Gewinn je Aktie · Tatsächlich | 0,46 | 0,64 | 0,38 | 0,44 | 0,38 | 0,53 | 0,43 | 0,53 |
| Abweichung | −2,43 % | – | −20,83 % | −12,00 % | −13,64 % | – | −2,27 % | +26,19 % |
| Umsatz · Tatsächlich | 7,33 Mrd. | 8,92 Mrd. | 6,89 Mrd. | 7,35 Mrd. | 7,19 Mrd. | 8,31 Mrd. | 7,48 Mrd. | 7,94 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 29. Dez. 2022 | – | 0,45 |
| 28. Juni 2022 | – | 0,44 |
| 29. Dez. 2021 | – | 0,45 |
| 28. Juni 2021 | 3. Sept. 2021 | 0,41 |
| 29. Dez. 2020 | 8. Apr. 2021 | 0,36 |
| 26. Juni 2020 | 3. Sept. 2020 | 0,38 |
| 27. Dez. 2019 | 6. Apr. 2020 | 0,74 |
| 26. Juni 2019 | 3. Sept. 2019 | 0,75 |
| 27. Dez. 2018 | 5. Apr. 2019 | 0,72 |
| 27. Juni 2018 | 4. Sept. 2018 | 0,72 |
| 27. Dez. 2017 | 6. Apr. 2018 | 0,80 |
| 27. Juni 2017 | – | 0,68 |
Aktiensplits
- 28. Aug. 20063:2
- 16. März 19985:1
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
AZPNAspen Technology, Inc.264,330,00 %
FLTFLEETCOR Technologies, Inc.303,26−0,83 %
GENGen Digital Inc.30,64+2,08 %
JNPRJuniper Networks, Inc.39,95+0,05 %
MKFGMarkforged Holding Corporation4,74−0,42 %
NETENet Element, Inc.13,09+8,63 %
SGEStrong Global Entertainment, Inc.1,55−2,52 %
SPLKSplunk Inc.156,90+0,25 %
Über das Unternehmen
Canon Inc. is a Japanese multinational corporation specializing in the production and distribution of a diverse array of advanced technological products. Its extensive offerings range from office solutions like multifunction devices (MFDs) and various types of printers (laser and inkjet) to consumer imaging products such as cameras, as well as sophisticated medical diagnostic systems and industrial lithography equipment. The company organizes its extensive operations into four primary units: Printing Business Unit, Imaging Business Unit, Medical System Business Unit, and Industrial and Others Business Unit. The Printing Business Unit encompasses a wide range of products for document management, including office MFDs, document solutions, laser multifunction and single-function printers, inkjet printers, image scanners, calculators, and high-volume digital printing presses (continuous feed and sheet-fed) and large format printers. The Imaging Business Unit focuses on visual technology, providing interchangeable-lens and compact digital cameras, lenses, compact photo printers, network cameras, video management and content analytics software, digital camcorders, digital cinema cameras, broadcast equipment, and multimedia projectors. Canon's Medical System Business Unit delivers advanced diagnostic and imaging solutions for healthcare, such as computed tomography (CT), diagnostic ultrasound, X-ray, and magnetic resonance imaging (MRI) systems, alongside clinical chemistry analyzers, digital radiography systems, and ophthalmic equipment. The Industrial and Others Business Unit addresses specialized manufacturing needs with products like semiconductor and flat panel display lithography equipment, vacuum thin-film deposition equipment, organic light-emitting diode (OLED) display manufacturing tools, die bonders, handy terminals, and document scanners. Beyond hardware, Canon also provides essential maintenance services and supplies consumables such as replacement drums, parts, toners, and paper. Operating under the globally recognized Canon brand, its products are distributed worldwide through a network of subsidiaries and independent distributors, reaching dealers, retail outlets, and directly serving end-users. Established in 1933, the company maintains its corporate headquarters in Tokyo, Japan.
Führung
- Fujio MitaraiChairman & Chief Executive Officer
- Toshizo TanakaChief Financial Officer, EVice President, Group Executive of Facilities Management, Public Affairs, F&A, Corporation Planning and Director
- Toshio HommaEVice President, Chief Technology Officer, Head of Printing Group & Director
- Hisahiro MinokawaManaging Executive Officer and Group Exec. of HR Management & Organization HQ
- Kenichi NagasawaGroup Executive of Corporation Intellectual Property & Legal HQ and Senior Managing Exec. Officer
- Hideki OzawaExecutive Vice President
- CEO
- Fujio Mitarai
- Mitarbeitende
- 184.034
- Hauptsitz
- Tokyo, JP
- Sektor
- Technology
- Branche
- Computer Hardware
- Börsengang
- 30. Aug. 2001
- Website
- global.canon
Nachrichten
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.